Propofol selectively inhibits nuclear factor-κB activity by suppressing p38 mitogen‑activated protein kinase signaling in human EA.hy926 endothelial cells during intermittent hypoxia/reoxygenation

Li,Dongliang; Wang,Chunling; Li,Ning; Zhang,Li

doi:10.3892/mmr.2014.1946

Propofol selectively inhibits nuclear factor-κB activity by suppressing p38 mitogen‑activated protein kinase signaling in human EA.hy926 endothelial cells during intermittent hypoxia/reoxygenation

Authors:
- Dongliang Li
- Chunling Wang
- Ning Li
- Li Zhang
View Affiliations

Affiliations: Department of Anesthesiology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China , School of Public Health, Jining Medical University, Jining, Shandong 272067, P.R. China, Department of Anesthesiology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: February 11, 2014 https://doi.org/10.3892/mmr.2014.1946
Pages: 1460-1466

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intermittent hypoxia/reoxygenation (IHR) induces proinflammatory cytokines, contributing to the pathogenic process of atherosclerosis associated with obstructive sleep apnea (OSA). Two transcription factors, nuclear factor‑κB (NF‑κB) and hypoxia‑inducible factor‑1 (HIF‑1), have been indicated to mediate proinflammatory cytokines during IHR. The anti‑inflammatory effects of propofol have attracted increasing attention in regard to the treament of multiple diseases associated with inflammation. The present study examined whether propofol inhibits NF‑κB and HIF‑1 activity in vascular endothelial cells during IHR. EA.hy926 endothelial cells were exposed to IHR for 64 cycles with or without propofol treatment. Gene knockdown by transfection of siRNA against p38 mitogen‑activated protein kinase (MAPK) was also used to investigate the molecular mechanisms. Compared with the control group, IHR exposure significantly induced the activation of NF‑κB and HIF‑1, enhanced the mRNA expression of proinflammatory cytokines and increased the activation of p38 MAPK. Propofol dose‑dependently inhibited the IHR‑induced activation of NF‑κB, but did not change the activation of HIF‑1, which was accompanied by decreased levels of proinflammatory cytokines. In addition, IHR‑induced p38 MAPK activity was attenuated by propofol in a similar manner to the reduction in NF‑κB activity. Furthermore, knockdown of p38 MAPK with siRNA significantly reduced the IHR‑induced activation of NF‑κB, while not affecting HIF‑1. These data demonstrate that propofol selectively attenuates the IHR‑induced activation of NF‑κB, but not HIF‑1, in vascular endothelial cells, and these beneficial effects are likely to be based on the inhibition of the p38 MAPK signaling pathway. Propofol may have the potential to prevent atherosclerosis in patients with OSA by inhibiting NF‑κB‑mediated inflammation in the vascular endothelium.

View Figures

View References

1	Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM and Mohsenin V: Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 353:2034–2041. 2005. View Article : Google Scholar : PubMed/NCBI
2	Quan SF and Gersh BJ; National Center on Sleep Disorders Research; National Heart, Lung, and Blood Institute. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation. 109:951–957. 2004. View Article : Google Scholar
3	Fang G, Song D, Ye X, Mao SZ, Liu G and Liu SF: Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50. Am J Pathol. 181:1530–1539. 2012.PubMed/NCBI
4	Lan L, Tao J, Chen A, et al: Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-κB pathway. Int J Mol Med. 31:75–80. 2013.PubMed/NCBI
5	Tang Z, Jiang L, Peng J, et al: PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages. Int J Mol Med. 30:931–938. 2012.PubMed/NCBI
6	Abe J: Role of PKCs and NF-kappaB activation in myocardial inflammation: enemy or ally? J Mol Cell Cardiol. 43:404–408. 2007. View Article : Google Scholar : PubMed/NCBI
7	Ryan S, McNicholas WT and Taylor CT: A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation. Biochem Biophys Res Commun. 355:728–733. 2007. View Article : Google Scholar : PubMed/NCBI
8	Han Q, Yeung SC, Ip MS and Mak JC: Intermittent hypoxia-induced NF-κB and HO-1 regulation in human endothelial EA.hy926 cells. Cell Biochem Biophys. 66:431–441. 2013.
9	Song D, Fang G, Mao SZ, et al: Chronic intermittent hypoxia induces atherosclerosis by NF-κB-dependent mechanisms. Biochim Biophys Acta. 1822:1650–1659. 2012.
10	Htoo AK, Greenberg H, Tongia S, et al: Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath. 10:43–50. 2006. View Article : Google Scholar : PubMed/NCBI
11	Ryan S, Taylor CT and McNicholas WT: Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 112:2660–2667. 2005. View Article : Google Scholar : PubMed/NCBI
12	Ryan S, Taylor CT and McNicholas WT: Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax. 64:631–636. 2009.
13	Marik PE: Propofol: an immunomodulating agent. Pharmacotherapy. 25:28S–33S. 2005. View Article : Google Scholar : PubMed/NCBI
14	Tang J, Chen X, Tu W, et al: Propofol inhibits the activation of p38 through up-regulating the expression of annexin A1 to exert its anti-inflammation effect. PLoS One. 6:e278902011. View Article : Google Scholar : PubMed/NCBI
15	Li H, Tan J, Zou Z, Huang CG and Shi XY: Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway. Eur J Anaesthesiol. 28:525–534. 2011. View Article : Google Scholar
16	Drager LF, Polotsky VY and Lorenzi-Filho G: Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest. 140:534–542. 2011. View Article : Google Scholar : PubMed/NCBI
17	Arnaud C, Dematteis M, Pepin JL, Baguet JP and Lévy P: Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol. 31:113–125. 2009. View Article : Google Scholar : PubMed/NCBI
18	Endemann DH and Schiffrin EL: Endothelial dysfunction. J Am Soc Nephrol. 15:1983–1992. 2004. View Article : Google Scholar
19	Kutuk O and Basaga H: Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis. Apoptosis. 11:1661–1675. 2006. View Article : Google Scholar : PubMed/NCBI
20	Martinet W and Kockx MM: Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr Opin Lipidol. 12:535–541. 2001. View Article : Google Scholar : PubMed/NCBI
21	Thurberg BL and Collins T: The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol. 9:387–396. 1998. View Article : Google Scholar : PubMed/NCBI
22	Yeh CH, Cho W, So EC, et al: Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1alpha expression. Br J Anaesth. 106:590–599. 2011. View Article : Google Scholar : PubMed/NCBI
23	Li S, Qian XH, Zhou W, et al: Time-dependent inflammatory factor production and NFκB activation in a rodent model of intermittent hypoxia. Swiss Med Wkly. 141:w133092011.
24	Tanaka T, Takabuchi S, Nishi K, et al: The intravenous anesthetic propofol inhibits lipopolysaccharide-induced hypoxia-inducible factor 1 activation and suppresses the glucose metabolism in macrophages. J Anesth. 24:54–60. 2010. View Article : Google Scholar
25	He XY, Shi XY, Yuan HB, Xu HT, Li YK and Zou Z: Propofol attenuates hypoxia-induced apoptosis in alveolar epithelial type II cells through down-regulating hypoxia-inducible factor-1α. Injury. 43:279–283. 2012.PubMed/NCBI
26	Lee SH, Lee YJ and Han HJ: Effect of arachidonic acid on hypoxia-induced IL-6 production in mouse ES cells: Involvement of MAPKs, NF-kappaB, and HIF-1alpha. J Cell Physiol. 222:574–585. 2010.PubMed/NCBI
27	Kumar S, Boehm J and Lee JC: p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2:717–726. 2003. View Article : Google Scholar : PubMed/NCBI
28	Karin M: Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc. 2:386–390. 2005. View Article : Google Scholar : PubMed/NCBI